231 related articles for article (PubMed ID: 22917564)
1. CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling.
Cao Z; Ren D; Ha T; Liu L; Wang X; Kalbfleisch J; Gao X; Kao R; Williams D; Li C
Biochim Biophys Acta; 2013 Jan; 1832(1):96-104. PubMed ID: 22917564
[TBL] [Abstract][Full Text] [Related]
2. The TLR9 ligand, CpG-ODN, induces protection against cerebral ischemia/reperfusion injury via activation of PI3K/Akt signaling.
Lu C; Ha T; Wang X; Liu L; Zhang X; Kimbrough EO; Sha Z; Guan M; Schweitzer J; Kalbfleisch J; Williams D; Li C
J Am Heart Assoc; 2014 Apr; 3(2):e000629. PubMed ID: 24721797
[TBL] [Abstract][Full Text] [Related]
3. Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling.
Xie L; He S; Kong N; Zhu Y; Tang Y; Li J; Liu Z; Liu J; Gong J
Cell Physiol Biochem; 2018; 47(4):1389-1398. PubMed ID: 29929196
[TBL] [Abstract][Full Text] [Related]
4. The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling.
Gao M; Ha T; Zhang X; Wang X; Liu L; Kalbfleisch J; Singh K; Williams D; Li C
J Infect Dis; 2013 May; 207(9):1471-9. PubMed ID: 23359590
[TBL] [Abstract][Full Text] [Related]
5. The TLR9 Antagonist iCpG-ODN at Different Dosages Inhibits Cerebral Ischemia/Reperfusion Injury in Mice.
Zhou Y; Pan J; Peng Q; Dong Z; Deng L; Wang Y
CNS Neurol Disord Drug Targets; 2017; 16(5):624-633. PubMed ID: 28176622
[TBL] [Abstract][Full Text] [Related]
6. The toll-like receptor 9 agonist, CpG-oligodeoxynucleotide 1826, ameliorates cardiac dysfunction after trauma-hemorrhage.
Zhang X; Gao M; Ha T; Kalbfleisch JH; Williams DL; Li C; Kao RL
Shock; 2012 Aug; 38(2):146-52. PubMed ID: 22576005
[TBL] [Abstract][Full Text] [Related]
7. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Ha T; Hu Y; Liu L; Lu C; McMullen JR; Kelley J; Kao RL; Williams DL; Gao X; Li C
Cardiovasc Res; 2010 Sep; 87(4):694-703. PubMed ID: 20421349
[TBL] [Abstract][Full Text] [Related]
8. Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model.
Kim SC; Wu S; Fang X; Neumann J; Eichhorn L; Schleifer G; Boehm O; Meyer R; Frede S; Hoeft A; Baumgarten G; Knuefermann P
Life Sci; 2014 Dec; 119(1-2):1-8. PubMed ID: 25445440
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism.
Ha T; Hua F; Liu X; Ma J; McMullen JR; Shioi T; Izumo S; Kelley J; Gao X; Browder W; Williams DL; Kao RL; Li C
Cardiovasc Res; 2008 Jun; 78(3):546-53. PubMed ID: 18267957
[TBL] [Abstract][Full Text] [Related]
10. CpG oligodeoxynucleotide preconditioning improves cardiac function after myocardial infarction via modulation of energy metabolism and angiogenesis.
Zhou DC; Su YH; Jiang FQ; Xia JB; Wu HY; Chang ZS; Peng WT; Song GH; Park KS; Kim SK; Cai DQ; Zheng L; Qi XF
J Cell Physiol; 2018 May; 233(5):4245-4257. PubMed ID: 29057537
[TBL] [Abstract][Full Text] [Related]
11. CpG-ODN attenuates pathological cardiac hypertrophy and heart failure by activation of PI3Kα-Akt signaling.
Yang L; Cai X; Liu J; Jia Z; Jiao J; Zhang J; Li C; Li J; Tang XD
PLoS One; 2013; 8(4):e62373. PubMed ID: 23638055
[TBL] [Abstract][Full Text] [Related]
12. The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.
Liu S; Ai Q; Feng K; Li Y; Liu X
Apoptosis; 2016 Dec; 21(12):1366-1385. PubMed ID: 27738772
[TBL] [Abstract][Full Text] [Related]
13. Poly(I:C) preconditioning protects the heart against myocardial ischemia/reperfusion injury through TLR3/PI3K/Akt-dependent pathway.
Chen E; Chen C; Niu Z; Gan L; Wang Q; Li M; Cai X; Gao R; Katakam S; Chen H; Zhang S; Zhou R; Cheng X; Qiu Y; Yu H; Zhu T; Liu J
Signal Transduct Target Ther; 2020 Nov; 5(1):216. PubMed ID: 33154351
[TBL] [Abstract][Full Text] [Related]
14. Syringic acid mitigates myocardial ischemia reperfusion injury by activating the PI3K/Akt/GSK-3β signaling pathway.
Liu G; Zhang BF; Hu Q; Liu XP; Chen J
Biochem Biophys Res Commun; 2020 Oct; 531(2):242-249. PubMed ID: 32798018
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
Min J; Wei C
Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632
[TBL] [Abstract][Full Text] [Related]
16. TRAIL is involved in CpG ODN-mediated anti-apoptotic signals.
Lim EJ; Park DW; Jeong TW; Chin BR; Bae YS; Baek SH
Oncol Rep; 2012 Apr; 27(4):1213-8. PubMed ID: 22159760
[TBL] [Abstract][Full Text] [Related]
17. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-26a involved in Toll-like receptor 9‑mediated lung cancer growth and migration.
Jiang DS; Wang YW; Jiang J; Li SM; Liang SZ; Fang HY
Int J Mol Med; 2014 Jul; 34(1):307-12. PubMed ID: 24788552
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia.
Wang M; Wang Y; Weil B; Abarbanell A; Herrmann J; Tan J; Kelly M; Meldrum DR
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R972-8. PubMed ID: 19211725
[TBL] [Abstract][Full Text] [Related]
20. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
